Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus (Tulip SC)

First posted May, 2021, Updated September, 2021; Recruiting CATEGORIES: Lupus The purpose of this Phase 3 study is evaluating the efficacy and safety of SC anifrolumab in adult patients with moderate -to-severe SLE despite receiving standard therapy. To Learn More Contact AstraZeneca Clinical Study Information Center at 1-877-240-9479 or email identifier (NCT number): …

Read More

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up